Trial Review

Technical difficulties have been reported by some users of the search function and is being investigated by technical staff. Thank you for your patience and apologies for any inconvenience caused.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT01130246




Registration number
NCT01130246
Ethics application status
Date submitted
19/04/2010
Date registered
25/05/2010
Date last updated
31/10/2012

Titles & IDs
Public title
VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome
Scientific title
VISTA-16 Trial: Evaluation of the Safety and Efficacy of Short-Term A-002 Treatment in Subjects With Acute Coronary Syndromes
Secondary ID [1] 0 0
AN-CVD2233
Universal Trial Number (UTN)
Trial acronym
VISTA-16
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Acute Coronary Syndrome 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Coronary heart disease
Other 0 0 0 0
Research that is not of generic health relevance and not applicable to specific health categories listed above

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - A-002, varespladib methyl
Treatment: Drugs - Placebo

Experimental: A-002 500 mg - Once daily oral administration

Placebo Comparator: Matched Placebo - Once daily oral administration


Treatment: Drugs: A-002, varespladib methyl
A-002 administered once daily in addition to atorvastatin and standard of care

Treatment: Drugs: Placebo
Placebo administered once daily in addition to atorvastatin and standard of care
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Primary Objective of the Study
Timepoint [1] 0 0
16 weeks
Secondary outcome [1] 0 0
Secondary Objective of the Study
Timepoint [1] 0 0
2, 4, 8, 16 weeks and 6 months

Eligibility
Key inclusion criteria
1. Men and women =40 years of age

2. Written informed consent from the subject

3. A diagnosis of unstable angina, non-ST-segment elevation myocardial infarction
(NSTEMI), or ST-segment elevation myocardial infarction (STEMI)

Unstable angina is defined as:

- Chest pain symptomatic of ischemia or angina occurring at rest or on minimal
exertion with a pattern of increasing frequency or severity, lasting >10 minutes
and consistent with myocardial ischemia within 24 hours prior to hospitalization
and

- New or dynamic ST-segment depression or prominent T-wave inversion changes in at
least 2 contiguous leads and

- In addition subjects meeting the above criteria for unstable angina must also
have either troponin I, troponin T or CKMB above the LLD but below the 99th
percentile of the upper reference limit (URL) and not due to cardioversion or
underlying cardiovascular (CHF, cardiomyopathy) or renal disease

NSTEMI is defined as:

- Chest pain symptomatic of ischemia

- No electrocardiogram (ECG) changes, or ST-depression, or T wave changes(i.e., no
new Q waves on serial ECGs)and

- Increase in cardiac troponin > local limit for the definition of myocardial
infarction or increase in CK-MB isoenzyme > URL

STEMI is defined as:

- Chest pain symptomatic of ischemia

- ST segment elevation and associated T wave changes or ST-segment elevation of at
least 2 mm in 2 contiguous leads, either of which persisting for longer than 15
minutes and

- Increase in cardiac troponin > local limit for the definition of myocardial
infarction or increase in CK-MB >URL

4. All subjects must have the presence of at least one of the following risk factors:

- Diabetes Mellitus or

- Presence of any 3 of the following characteristics of metabolic syndrome

- Waist circumference >102 cm in males, >88 cm in females

- Serum triglycerides =150 mg/dL (=1.7 mmol/L)

- HDL-C <40 mg/dL (<1 mmol/L) in males, <50 mg/dL (<1.3 mmol/L) in females

- Blood pressure =130/85 mmHg

- Plasma glucose =110 mg/dL (=6.1 mmol/L) or

- history of cerebrovascular disease (stroke or TIA) or

- history of peripheral vascular disease or

- previous CABG or

- previous documented myocardial infarction or

- previous coronary revascularization

5. Subjects must be randomized within =96 hours of hospital admission for the index
event, or if already hospitalized, within =96 hours of index event diagnosis

6. Revascularization, if required or planned, must occur prior to randomization
Minimum age
40 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Subjects enrolled in another experimental (interventional)protocol within the past 30
days prior to Screening.

2. Subjects treated for cancer within the previous 5 years except for skin basal cell
carcinoma or carcinoma in situ of the cervix, with measures other than a minor,
complete surgical excision or radiation therapy (e.g. chemotherapy)

3. The presence of any severe liver disease with cirrhosis, active hepatitis, active
chronic hepatitis, alanine aminotransferase (ALT) or aspartate aminotransferase (AST)
>3 x ULN, biliary obstruction with hyperbilirubinemia (total bilirubin >2 x ULN)

4. Active cholecystitis, gall bladder symptoms, or any hepatobiliary abnormalities

5. The presence of severe renal impairment (creatinine clearance [CrCl] <30 mL/min or
creatinine >3 x ULN),nephrotic syndrome, or subjects undergoing dialysis

6. Uncontrolled diabetes mellitus (known hemoglobin A1c [HbA1c] >11% within the last 1
month prior to Screening)

7. Females who are nursing, pregnant, or intend to become pregnant during the time of the
study, or females of childbearing potential who have a positive pregnancy test during
screening evaluation. Women of child-bearing potential must also use a reliable method
of birth control during the study and for 1 month following completion of therapy. A
reliable method for this study is defined as one of the following: oral or injectable
contraceptives, intrauterine device (IUD), contraceptive implants, tubal ligation,
hysterectomy, a double barrier method (diaphragm with spermicidal foam or jelly, or a
condom).

8. Subjects who have a history of alcohol or drug abuse within 1 year of study entry

9. Subjects living too far from participating center or unable to return for follow-up
visits

10. Subjects who in the opinion of the Investigator are a poor medical or psychiatric risk
for therapy with an investigational drug, are unreliable, or have an incomplete
understanding of the study which may affect their ability to take drugs as prescribed
or comply with instructions

11. Known human immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus
(HCV), or tuberculosis infection

12. Acute bacterial, fungal or viral infection

13. Subjects currently taking drugs that are potent inhibitors of cytochrome P450 unless
they can be withdrawn

14. Subjects with New York Heart Association (NYHA) Class III or IV heart failure, or if
known, left ventricular ejection fraction (LVEF) <30

15. Subjects with moderate or severe aortic stenosis, aortic regurgitation, mitral
stenosis or mitral regurgitation

16. Ventricular arrhythmias requiring chronic drug treatment or implantable
cardioverter-defibrillator (ICD)

17. Subjects with no stenosis or stenosis <50% on angiography, if known

18. Subjects with a pacemaker or persistent left bundle branch block (LBBB)

19. Fasting triglyceride levels of =400 mg/dL (4.5 mmol/L)

20. Subjects who have a history of statin intolerance or a significant myopathy or
rhabdomyolysis with any lipid altering drugs

21. Subjects currently treated with the maximum labeled dose of a statin and not at LDL-C
target for their level of risk as defined by NCEP ATP III

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Terminated
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/05/2010
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/03/2012
Sample size
Target
Accrual to date
Final
5189
Recruitment in Australia
Recruitment state(s)
ACT,NSW,QLD,SA,TAS,VIC,WA
Recruitment hospital [1] 0 0
Investigator Site 6106 - Canberra
Recruitment hospital [2] 0 0
Investigator Site 6114 - Gosford
Recruitment hospital [3] 0 0
Investigator Site 6120 - Kingswood
Recruitment hospital [4] 0 0
Investigator Site 6113 - Cairns
Recruitment hospital [5] 0 0
Investigator Site 6112 - Douglas
Recruitment hospital [6] 0 0
Investigator Site 6123 - Nambour
Recruitment hospital [7] 0 0
Investigator Site 6111 - Adelaide
Recruitment hospital [8] 0 0
Investigator Site 6124 - Bedford Park
Recruitment hospital [9] 0 0
Investigator Site 6103 - Elizabeth Vale
Recruitment hospital [10] 0 0
Investigator Site 6122 - Hobart
Recruitment hospital [11] 0 0
Investigator Site 6129 - Epping
Recruitment hospital [12] 0 0
Investigator Site 6127 - Heidelberg
Recruitment hospital [13] 0 0
Investigator Site 6125 - Perth
Recruitment hospital [14] 0 0
Investigator Site 6130 - Perth
Recruitment hospital [15] 0 0
Investigator Site 6118 - Brisbane
Recruitment hospital [16] 0 0
Investigator Site 6126 - Geelong
Recruitment hospital [17] 0 0
Investigator Site 6101 - Kogarah
Recruitment hospital [18] 0 0
Investigator Site 6105 - Melbourne
Recruitment hospital [19] 0 0
Investigator Site 6110 - Nedlands
Recruitment hospital [20] 0 0
Investigator Site 6121 - New Lambton
Recruitment hospital [21] 0 0
Investigator Site 6108 - So Australia
Recruitment hospital [22] 0 0
Investigator Site 6119 - South Port
Recruitment postcode(s) [1] 0 0
- Canberra
Recruitment postcode(s) [2] 0 0
2250 - Gosford
Recruitment postcode(s) [3] 0 0
2747 - Kingswood
Recruitment postcode(s) [4] 0 0
4870 - Cairns
Recruitment postcode(s) [5] 0 0
4814 - Douglas
Recruitment postcode(s) [6] 0 0
4560 - Nambour
Recruitment postcode(s) [7] 0 0
5000 - Adelaide
Recruitment postcode(s) [8] 0 0
5042 - Bedford Park
Recruitment postcode(s) [9] 0 0
5112 - Elizabeth Vale
Recruitment postcode(s) [10] 0 0
7000 - Hobart
Recruitment postcode(s) [11] 0 0
3076 - Epping
Recruitment postcode(s) [12] 0 0
3084 - Heidelberg
Recruitment postcode(s) [13] 0 0
6000 - Perth
Recruitment postcode(s) [14] 0 0
- Brisbane
Recruitment postcode(s) [15] 0 0
- Geelong
Recruitment postcode(s) [16] 0 0
NSW2217 - Kogarah
Recruitment postcode(s) [17] 0 0
3004 - Melbourne
Recruitment postcode(s) [18] 0 0
6009 - Nedlands
Recruitment postcode(s) [19] 0 0
NSW2305 - New Lambton
Recruitment postcode(s) [20] 0 0
- So Australia
Recruitment postcode(s) [21] 0 0
4215QLD - South Port
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Connecticut
Country [6] 0 0
United States of America
State/province [6] 0 0
Delaware
Country [7] 0 0
United States of America
State/province [7] 0 0
District of Columbia
Country [8] 0 0
United States of America
State/province [8] 0 0
Florida
Country [9] 0 0
United States of America
State/province [9] 0 0
Georgia
Country [10] 0 0
United States of America
State/province [10] 0 0
Illinois
Country [11] 0 0
United States of America
State/province [11] 0 0
Louisiana
Country [12] 0 0
United States of America
State/province [12] 0 0
Michigan
Country [13] 0 0
United States of America
State/province [13] 0 0
Minnesota
Country [14] 0 0
United States of America
State/province [14] 0 0
Mississippi
Country [15] 0 0
United States of America
State/province [15] 0 0
Montana
Country [16] 0 0
United States of America
State/province [16] 0 0
Nebraska
Country [17] 0 0
United States of America
State/province [17] 0 0
New Jersey
Country [18] 0 0
United States of America
State/province [18] 0 0
New York
Country [19] 0 0
United States of America
State/province [19] 0 0
North Carolina
Country [20] 0 0
United States of America
State/province [20] 0 0
North Dakota
Country [21] 0 0
United States of America
State/province [21] 0 0
Ohio
Country [22] 0 0
United States of America
State/province [22] 0 0
Oklahoma
Country [23] 0 0
United States of America
State/province [23] 0 0
Oregon
Country [24] 0 0
United States of America
State/province [24] 0 0
Pennsylvania
Country [25] 0 0
United States of America
State/province [25] 0 0
Rhode Island
Country [26] 0 0
United States of America
State/province [26] 0 0
South Dakota
Country [27] 0 0
United States of America
State/province [27] 0 0
Tennessee
Country [28] 0 0
United States of America
State/province [28] 0 0
Texas
Country [29] 0 0
United States of America
State/province [29] 0 0
Utah
Country [30] 0 0
United States of America
State/province [30] 0 0
Virginia
Country [31] 0 0
United States of America
State/province [31] 0 0
Wisconsin
Country [32] 0 0
Canada
State/province [32] 0 0
Alberta
Country [33] 0 0
Canada
State/province [33] 0 0
British Columbia
Country [34] 0 0
Canada
State/province [34] 0 0
Newfoundland and Labrador
Country [35] 0 0
Canada
State/province [35] 0 0
Nova Scotia
Country [36] 0 0
Canada
State/province [36] 0 0
Ontario
Country [37] 0 0
Canada
State/province [37] 0 0
Quebec
Country [38] 0 0
Canada
State/province [38] 0 0
Saint John
Country [39] 0 0
Czech Republic
State/province [39] 0 0
Brno
Country [40] 0 0
Czech Republic
State/province [40] 0 0
Labem
Country [41] 0 0
Czech Republic
State/province [41] 0 0
Stare Mesto
Country [42] 0 0
Czech Republic
State/province [42] 0 0
Hradec Kralove
Country [43] 0 0
Czech Republic
State/province [43] 0 0
Jihlava
Country [44] 0 0
Czech Republic
State/province [44] 0 0
Mlada Boleslav
Country [45] 0 0
Czech Republic
State/province [45] 0 0
Nymburk
Country [46] 0 0
Czech Republic
State/province [46] 0 0
Olomouc
Country [47] 0 0
Czech Republic
State/province [47] 0 0
Ostrava
Country [48] 0 0
Czech Republic
State/province [48] 0 0
Plzen
Country [49] 0 0
Czech Republic
State/province [49] 0 0
Praha 2
Country [50] 0 0
Czech Republic
State/province [50] 0 0
Praha 5
Country [51] 0 0
Czech Republic
State/province [51] 0 0
Praha
Country [52] 0 0
Czech Republic
State/province [52] 0 0
Usti nad Labem
Country [53] 0 0
Czech Republic
State/province [53] 0 0
Znojmo
Country [54] 0 0
Georgia
State/province [54] 0 0
Tbilisi
Country [55] 0 0
Germany
State/province [55] 0 0
Am Krankenhaus
Country [56] 0 0
Germany
State/province [56] 0 0
Bad Friedrichshall
Country [57] 0 0
Germany
State/province [57] 0 0
Bad Nauheim
Country [58] 0 0
Germany
State/province [58] 0 0
Berlin
Country [59] 0 0
Germany
State/province [59] 0 0
Bielefeld
Country [60] 0 0
Germany
State/province [60] 0 0
Bonn
Country [61] 0 0
Germany
State/province [61] 0 0
Dortmund
Country [62] 0 0
Germany
State/province [62] 0 0
Erfurt
Country [63] 0 0
Germany
State/province [63] 0 0
Goettingen
Country [64] 0 0
Germany
State/province [64] 0 0
Hamburg
Country [65] 0 0
Germany
State/province [65] 0 0
Kassel
Country [66] 0 0
Germany
State/province [66] 0 0
Kiel
Country [67] 0 0
Germany
State/province [67] 0 0
Limburg
Country [68] 0 0
Germany
State/province [68] 0 0
Lubeck
Country [69] 0 0
Germany
State/province [69] 0 0
Magdeburg
Country [70] 0 0
Germany
State/province [70] 0 0
Mainz
Country [71] 0 0
Germany
State/province [71] 0 0
Munchen
Country [72] 0 0
Germany
State/province [72] 0 0
Nauen
Country [73] 0 0
Germany
State/province [73] 0 0
Regensburg
Country [74] 0 0
Germany
State/province [74] 0 0
Ulm
Country [75] 0 0
Hungary
State/province [75] 0 0
Baranya Megye
Country [76] 0 0
Hungary
State/province [76] 0 0
Fejer Megye
Country [77] 0 0
Hungary
State/province [77] 0 0
Gaal Jozsef
Country [78] 0 0
Hungary
State/province [78] 0 0
Hajdu-Bihar
Country [79] 0 0
Hungary
State/province [79] 0 0
Kistarcsa
Country [80] 0 0
Hungary
State/province [80] 0 0
Pest Megye
Country [81] 0 0
Hungary
State/province [81] 0 0
Szolnok Megye
Country [82] 0 0
Hungary
State/province [82] 0 0
Zala Megye
Country [83] 0 0
Hungary
State/province [83] 0 0
Balatonfured
Country [84] 0 0
Hungary
State/province [84] 0 0
Budapest
Country [85] 0 0
Hungary
State/province [85] 0 0
Eger
Country [86] 0 0
Hungary
State/province [86] 0 0
Hodmezovasarhely
Country [87] 0 0
Hungary
State/province [87] 0 0
Sopron
Country [88] 0 0
Hungary
State/province [88] 0 0
Szombathely
Country [89] 0 0
India
State/province [89] 0 0
Andhra Pradesh
Country [90] 0 0
India
State/province [90] 0 0
Delhi
Country [91] 0 0
India
State/province [91] 0 0
Gujarat
Country [92] 0 0
India
State/province [92] 0 0
Karanataka
Country [93] 0 0
India
State/province [93] 0 0
Karnataka
Country [94] 0 0
India
State/province [94] 0 0
Madhya Pradesh
Country [95] 0 0
India
State/province [95] 0 0
Maharashtra
Country [96] 0 0
India
State/province [96] 0 0
Uttar Pradesh
Country [97] 0 0
India
State/province [97] 0 0
West Bengal
Country [98] 0 0
Italy
State/province [98] 0 0
Via L Bissolati
Country [99] 0 0
Italy
State/province [99] 0 0
Cecina
Country [100] 0 0
Italy
State/province [100] 0 0
Colleferro
Country [101] 0 0
Italy
State/province [101] 0 0
Ferrara
Country [102] 0 0
Italy
State/province [102] 0 0
Massa
Country [103] 0 0
Italy
State/province [103] 0 0
Milano
Country [104] 0 0
Italy
State/province [104] 0 0
Monza
Country [105] 0 0
Italy
State/province [105] 0 0
Napoli
Country [106] 0 0
Italy
State/province [106] 0 0
Novara
Country [107] 0 0
Italy
State/province [107] 0 0
Roma
Country [108] 0 0
Italy
State/province [108] 0 0
Rome
Country [109] 0 0
Italy
State/province [109] 0 0
Rozzano (MI)
Country [110] 0 0
Italy
State/province [110] 0 0
Siena
Country [111] 0 0
Korea, Republic of
State/province [111] 0 0
Busan
Country [112] 0 0
Korea, Republic of
State/province [112] 0 0
Cheongju
Country [113] 0 0
Korea, Republic of
State/province [113] 0 0
Daegu
Country [114] 0 0
Korea, Republic of
State/province [114] 0 0
Daejeon
Country [115] 0 0
Korea, Republic of
State/province [115] 0 0
Gwangju
Country [116] 0 0
Korea, Republic of
State/province [116] 0 0
Gyeonggi-do
Country [117] 0 0
Korea, Republic of
State/province [117] 0 0
Kangwon-do
Country [118] 0 0
Korea, Republic of
State/province [118] 0 0
Seoul
Country [119] 0 0
Korea, Republic of
State/province [119] 0 0
Suwon
Country [120] 0 0
Lebanon
State/province [120] 0 0
Jnah
Country [121] 0 0
Lebanon
State/province [121] 0 0
Beirut
Country [122] 0 0
Netherlands
State/province [122] 0 0
CM
Country [123] 0 0
Netherlands
State/province [123] 0 0
RA
Country [124] 0 0
Netherlands
State/province [124] 0 0
Amstelveen
Country [125] 0 0
Netherlands
State/province [125] 0 0
Amsterdam
Country [126] 0 0
Netherlands
State/province [126] 0 0
Breda
Country [127] 0 0
Netherlands
State/province [127] 0 0
Delft
Country [128] 0 0
Netherlands
State/province [128] 0 0
Den Helder
Country [129] 0 0
Netherlands
State/province [129] 0 0
Deventer
Country [130] 0 0
Netherlands
State/province [130] 0 0
Ede
Country [131] 0 0
Netherlands
State/province [131] 0 0
Heerlen
Country [132] 0 0
Netherlands
State/province [132] 0 0
Hoogeveen
Country [133] 0 0
Netherlands
State/province [133] 0 0
Leeuwarden
Country [134] 0 0
Netherlands
State/province [134] 0 0
Leiden
Country [135] 0 0
Netherlands
State/province [135] 0 0
Purmerend
Country [136] 0 0
Netherlands
State/province [136] 0 0
Roosendaal
Country [137] 0 0
Netherlands
State/province [137] 0 0
Rotterdam
Country [138] 0 0
Netherlands
State/province [138] 0 0
Schiedam
Country [139] 0 0
Netherlands
State/province [139] 0 0
Sneek
Country [140] 0 0
Netherlands
State/province [140] 0 0
Tilburg
Country [141] 0 0
Netherlands
State/province [141] 0 0
Utrecht
Country [142] 0 0
Netherlands
State/province [142] 0 0
Venlo
Country [143] 0 0
Netherlands
State/province [143] 0 0
Zaandam
Country [144] 0 0
New Zealand
State/province [144] 0 0
Auckland
Country [145] 0 0
New Zealand
State/province [145] 0 0
Christchurch
Country [146] 0 0
New Zealand
State/province [146] 0 0
Dunedin
Country [147] 0 0
New Zealand
State/province [147] 0 0
Hamilton
Country [148] 0 0
New Zealand
State/province [148] 0 0
Wellington
Country [149] 0 0
Poland
State/province [149] 0 0
Dolnoslaskie
Country [150] 0 0
Poland
State/province [150] 0 0
Kujawsko-pomorskie
Country [151] 0 0
Poland
State/province [151] 0 0
Podkarpackie
Country [152] 0 0
Poland
State/province [152] 0 0
Pomorskie
Country [153] 0 0
Poland
State/province [153] 0 0
Bialystok
Country [154] 0 0
Poland
State/province [154] 0 0
Bytom
Country [155] 0 0
Poland
State/province [155] 0 0
Stalowa Wola
Country [156] 0 0
Poland
State/province [156] 0 0
Szczecin
Country [157] 0 0
Poland
State/province [157] 0 0
Warszawa
Country [158] 0 0
Poland
State/province [158] 0 0
Wroclaw
Country [159] 0 0
Russian Federation
State/province [159] 0 0
Barnaui
Country [160] 0 0
Russian Federation
State/province [160] 0 0
Chelyabinsk
Country [161] 0 0
Russian Federation
State/province [161] 0 0
Ekaterinburg
Country [162] 0 0
Russian Federation
State/province [162] 0 0
Irkutsk
Country [163] 0 0
Russian Federation
State/province [163] 0 0
Kazan
Country [164] 0 0
Russian Federation
State/province [164] 0 0
Kemerovo
Country [165] 0 0
Russian Federation
State/province [165] 0 0
Krasnoyarsk
Country [166] 0 0
Russian Federation
State/province [166] 0 0
Kursk
Country [167] 0 0
Russian Federation
State/province [167] 0 0
Leningrad
Country [168] 0 0
Russian Federation
State/province [168] 0 0
Moscow
Country [169] 0 0
Russian Federation
State/province [169] 0 0
Murmansk
Country [170] 0 0
Russian Federation
State/province [170] 0 0
Novosibirsk
Country [171] 0 0
Russian Federation
State/province [171] 0 0
Orenburg
Country [172] 0 0
Russian Federation
State/province [172] 0 0
Rostov-on-Don
Country [173] 0 0
Russian Federation
State/province [173] 0 0
Samara
Country [174] 0 0
Russian Federation
State/province [174] 0 0
Saratov
Country [175] 0 0
Russian Federation
State/province [175] 0 0
St. Petersburg
Country [176] 0 0
Russian Federation
State/province [176] 0 0
St.Petersburg
Country [177] 0 0
Russian Federation
State/province [177] 0 0
Tomsk
Country [178] 0 0
Russian Federation
State/province [178] 0 0
Tyumen
Country [179] 0 0
Spain
State/province [179] 0 0
Asturias
Country [180] 0 0
Spain
State/province [180] 0 0
Barcelona
Country [181] 0 0
Spain
State/province [181] 0 0
Madrid
Country [182] 0 0
Spain
State/province [182] 0 0
Murcia
Country [183] 0 0
Spain
State/province [183] 0 0
Navarra
Country [184] 0 0
Spain
State/province [184] 0 0
Pontevedra
Country [185] 0 0
Spain
State/province [185] 0 0
Vizcaya
Country [186] 0 0
Spain
State/province [186] 0 0
Albacete
Country [187] 0 0
Spain
State/province [187] 0 0
Girona
Country [188] 0 0
Spain
State/province [188] 0 0
Huelva
Country [189] 0 0
Spain
State/province [189] 0 0
Leganes
Country [190] 0 0
Spain
State/province [190] 0 0
Lleida
Country [191] 0 0
Spain
State/province [191] 0 0
Malaga
Country [192] 0 0
Spain
State/province [192] 0 0
Reus
Country [193] 0 0
Spain
State/province [193] 0 0
Santa Cruz de Tenerife
Country [194] 0 0
Spain
State/province [194] 0 0
Sevilla
Country [195] 0 0
Spain
State/province [195] 0 0
Utrera
Country [196] 0 0
Spain
State/province [196] 0 0
Valencia
Country [197] 0 0
Ukraine
State/province [197] 0 0
Dnipropetrovsk
Country [198] 0 0
Ukraine
State/province [198] 0 0
Ivano-Frankivsk
Country [199] 0 0
Ukraine
State/province [199] 0 0
Kharkiv
Country [200] 0 0
Ukraine
State/province [200] 0 0
Kiev
Country [201] 0 0
Ukraine
State/province [201] 0 0
Lviv
Country [202] 0 0
Ukraine
State/province [202] 0 0
Odessa
Country [203] 0 0
Ukraine
State/province [203] 0 0
Poltava

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Anthera Pharmaceuticals
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The objective of this study is to evaluate the safety and efficacy of short-term A-002
treatment on morbidity and mortality when added to atorvastatin and standard of care in
subjects with an acute coronary syndrome (ACS).
Trial website
https://clinicaltrials.gov/ct2/show/NCT01130246
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT01130246